These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD. Singh D, Abbott-Banner K, Bengtsson T, Newman K. Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30166326 [Abstract] [Full Text] [Related]
24. Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3). Mahler DA, Gifford AH, Satti A, Jessop N, Eckert JH, D'Andrea P, Mota F, Banerjee R. Respir Med; 2016 Jun; 115():39-45. PubMed ID: 27215502 [Abstract] [Full Text] [Related]
30. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Bateman ED, Ferguson GT, Barnes N, Gallagher N, Green Y, Henley M, Banerji D. Eur Respir J; 2013 Dec 10; 42(6):1484-94. PubMed ID: 23722616 [Abstract] [Full Text] [Related]